All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

MedyTox revenue reports

MedyTox financial reports, MedyTox annual revenue in 2024. When does MedyTox report revenue?
Add to widgets
Added to widgets

MedyTox total revenue, net income and dynamics of changes in South Korean won today

MedyTox net revenue for today is 31 823 410 350 ₩. The dynamics of MedyTox net income grew by 72 903 852 640 ₩ for the last reporting period. Net income, revenue and dynamics - the main financial indicators of MedyTox. The financial graph of MedyTox shows the values and changes of such indicators: total assets, net income, net revenue. The financial report chart on our website displays information by dates from 31/12/2018 to 31/03/2021. The financial report on the chart of MedyTox allows you to clearly see the dynamics of fixed assets.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021 31 823 410 350 ₩ -28.0872 % ↓ 55 176 307 990 ₩ +304.8 % ↑
31/12/2020 29 548 355 210 ₩ -31.949 % ↓ -17 727 544 650 ₩ -216.142 % ↓
30/09/2020 35 792 879 150 ₩ -25.992 % ↓ -43 757 570 ₩ -101.414 % ↓
30/06/2020 41 596 653 710 ₩ -24.414 % ↓ -5 897 963 050 ₩ -156.124 % ↓
30/09/2019 48 363 441 970 ₩ - 3 094 161 620 ₩ -
30/06/2019 55 032 338 650 ₩ - 10 508 771 890 ₩ -
31/03/2019 44 252 788 630 ₩ - 13 630 399 700 ₩ -
31/12/2018 43 420 899 510 ₩ - 15 263 632 600 ₩ -
Show:
to

MedyTox financial report charts

Dates of MedyTox finance reports: 31/12/2018, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The latest date of the financial report of MedyTox is 31/03/2021. Gross profit MedyTox is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit MedyTox is 16 243 252 380 ₩

MedyTox quarterly report dates

Cost of revenue MedyTox is the total cost of producing and distributing of products and services of a company. Cost of revenue MedyTox is 15 580 157 970 ₩ Total revenue MedyTox refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue MedyTox is 31 823 410 350 ₩ Operating income MedyTox is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income MedyTox is -4 412 797 460 ₩

Net income MedyTox is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income MedyTox is 55 176 307 990 ₩ Current assets MedyTox is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets MedyTox is 141 884 185 350 ₩ Total assets MedyTox refers to the total amount of assets owned by a person or entity. Total assets MedyTox is 553 379 945 530 ₩

31/03/2021 31/12/2020 30/09/2020 30/06/2020 30/09/2019 30/06/2019 31/03/2019 31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
16 243 252 380 ₩ 20 178 734 380 ₩ 12 198 170 560 ₩ 21 992 340 360 ₩ 30 439 418 030 ₩ 37 552 298 930 ₩ 31 513 245 120 ₩ 30 104 729 230 ₩
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
15 580 157 970 ₩ 9 369 620 830 ₩ 23 594 708 590 ₩ 19 604 313 350 ₩ 17 924 023 940 ₩ 17 480 039 720 ₩ 12 739 543 510 ₩ 13 316 170 280 ₩
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
31 823 410 350 ₩ 29 548 355 210 ₩ 35 792 879 150 ₩ 41 596 653 710 ₩ 48 363 441 970 ₩ 55 032 338 650 ₩ 44 252 788 630 ₩ 43 420 899 510 ₩
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - 48 363 441 970 ₩ 55 032 338 650 ₩ 44 252 788 630 ₩ 43 420 899 510 ₩
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-4 412 797 460 ₩ -11 569 209 450 ₩ -11 442 261 070 ₩ -4 122 335 360 ₩ 3 299 660 610 ₩ 11 253 447 770 ₩ 15 778 711 410 ₩ 15 891 975 370 ₩
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
55 176 307 990 ₩ -17 727 544 650 ₩ -43 757 570 ₩ -5 897 963 050 ₩ 3 094 161 620 ₩ 10 508 771 890 ₩ 13 630 399 700 ₩ 15 263 632 600 ₩
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
6 206 309 000 ₩ 9 730 059 000 ₩ 8 004 288 000 ₩ 7 909 167 000 ₩ 6 819 880 000 ₩ 6 432 174 000 ₩ 5 580 362 000 ₩ 4 563 305 000 ₩
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
36 236 207 810 ₩ 41 117 564 660 ₩ 47 235 140 220 ₩ 45 718 989 070 ₩ 45 063 781 360 ₩ 43 778 890 880 ₩ 28 474 077 220 ₩ 27 528 924 140 ₩
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
141 884 185 350 ₩ 138 711 258 940 ₩ 141 658 937 230 ₩ 147 737 463 030 ₩ 122 177 556 750 ₩ 117 939 182 190 ₩ 123 678 681 000 ₩ 116 431 673 410 ₩
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
553 379 945 530 ₩ 467 764 378 990 ₩ 460 275 745 620 ₩ 469 054 705 370 ₩ 418 369 561 660 ₩ 408 474 674 750 ₩ 402 586 327 000 ₩ 395 014 965 910 ₩
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
25 414 392 000 ₩ 43 993 403 000 ₩ 47 602 064 480 ₩ 43 151 485 300 ₩ 17 740 708 980 ₩ 9 311 284 120 ₩ 18 562 265 000 ₩ 19 247 421 000 ₩
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 124 470 801 950 ₩ 114 128 547 820 ₩ 107 191 484 000 ₩ 110 815 703 920 ₩
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 150 073 168 540 ₩ 141 305 928 400 ₩ 133 883 323 000 ₩ 137 773 326 040 ₩
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 35.87 % 34.59 % 33.26 % 34.88 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
329 458 842 230 ₩ 241 328 039 340 ₩ 240 488 894 620 ₩ 239 782 812 460 ₩ 264 573 417 960 ₩ 263 281 944 120 ₩ 264 110 024 000 ₩ 252 587 221 500 ₩
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - 11 681 839 910 ₩ 278 463 140 ₩ 14 385 897 000 ₩ 15 865 551 280 ₩

Last revenue report of MedyTox was 31/03/2021. According to last financial report total revenue in MedyTox was 31 823 410 350 South Korean won and changed by -28.0872% since last year. Net income in MedyTox was 55 176 307 990 ₩ in last quartal, net income changes to +304.8%.

Current cash MedyTox - the sum of all of the cash a company has on the date of report. Current cash MedyTox is 25 414 392 000 ₩

MedyTox stocks data

MedyTox financials